KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Opko Health (OPK) Shares Outstanding (Weighted Average) (2016 - 2025)

Opko Health (OPK) has disclosed Shares Outstanding (Weighted Average) for 16 consecutive years, with $751.1 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Shares Outstanding (Weighted Average) rose 8.23% year-over-year to $751.1 million, compared with a TTM value of $751.1 million through Dec 2025, up 8.23%, and an annual FY2025 reading of $751.1 million, up 8.23% over the prior year.
  • Shares Outstanding (Weighted Average) was $751.1 million for Q4 2025 at Opko Health, down from $788.0 million in the prior quarter.
  • Across five years, Shares Outstanding (Weighted Average) topped out at $788.0 million in Q2 2025 and bottomed at $640.9 million in Q1 2021.
  • Average Shares Outstanding (Weighted Average) over 5 years is $706.5 million, with a median of $702.0 million recorded in 2024.
  • The sharpest move saw Shares Outstanding (Weighted Average) rose 15.12% in 2022, then dropped 7.68% in 2024.
  • Year by year, Shares Outstanding (Weighted Average) stood at $648.1 million in 2021, then increased by 10.95% to $719.1 million in 2022, then increased by 4.55% to $751.8 million in 2023, then decreased by 7.68% to $694.0 million in 2024, then grew by 8.23% to $751.1 million in 2025.
  • Business Quant data shows Shares Outstanding (Weighted Average) for OPK at $751.1 million in Q4 2025, $788.0 million in Q2 2025, and $671.6 million in Q1 2025.